A $25 million NSW
Government facility will give patients with genetic diseases, cancers and viral
infections across Australia faster access to ground-breaking trial therapies.
Health and Medical Research Brad Hazzard, Minister for Jobs, Investment,
Tourism and Western Sydney, Stuart Ayres and Member for Parramatta Geoff Lee
today announced the NSW Government is investing $25 million to build an
advanced viral vector manufacturing facility at the Westmead Health and
shortage in manufacture of viral vectors and plasmids – key components of gene
and cell therapies – has led to a two year wait worldwide,” Mr Hazzard said.
will produce clinical grade viral vectors on our home ground, significantly
cutting waiting times for patients across Australia to give them the best
Western Sydney Local Health District and Sydney Children’s Hospitals Network
have partnered with the University of Sydney to establish the facility.
Mr Ayres said the
Westmead Health Precinct is one of the largest health, education, research and
training precincts in Australia and a key provider of jobs for the greater
Parramatta and Western Sydney region.
Government will seek to unlock the opportunities within the Westmead Health and
Innovation Precinct in order to grow sectors and industries, like gene and cell
therapies, which have the potential to attract a significant number of jobs,
spur innovation and help to save lives and cure diseases.”
Mr Lee said the
manufacturing facility is not only a tremendous boost for Parramatta but will
reinforce NSW’s position as a global leader in developing gene and cell
proudly house the manufacturing hub for new treatments for diseases such as
spinal muscular atrophy, the leading genetic cause of infant death in
Australia,” Mr Lee said.
In 2019-20, the NSW Government is investing $108 million in medical and
scientific innovation, including further support for researchers in this area.